- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Absci Corp (ABSI)
Absci Corp stock price live, this page displays NASDAQ ABSI stock exchange data. View the ABSI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Absci Corp real time stock price chart below.
What Is the Absci Corp Stock Price Today?
The Absci Corp stock price today is 2.640.
What Is the Stock Symbol for Absci Corp?
The stock symbol for Absci Corp is "ABSI."
What Stock Exchange Does Absci Corp Trade On?
Absci Corp is listed and trades on the NASDAQ stock exchange.
Is Absci Corp a Good Stock to Buy?
Determining whether Absci Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABSI quote. (ISIN: US00091E1091)
What Is the Absci Corp Stock Price Today?
The Absci Corp stock price today is 2.640.
What Is the Stock Symbol for Absci Corp?
The stock symbol for Absci Corp is "ABSI."
What Stock Exchange Does Absci Corp Trade On?
Absci Corp is listed and trades on the NASDAQ stock exchange.
Is Absci Corp a Good Stock to Buy?
Determining whether Absci Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABSI quote. (ISIN: US00091E1091)
NASDAQ
Currency in USD
2.640
+0.060(+2.33%)
Closed·
Pre Market
2.720+0.080(+3.03%)
·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.605
2.760
52 wk Range
2.010
6.330
ABSI Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ABSI is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.6052.760
52 wk Range
2.0106.330
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ABSI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
9.125
Upside
+245.64%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- iRhythm Technologies announces Board changes
- Investing.com
- Absci receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- iRhythm Technologies announces Board changes
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Absci Company Profile
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, and Owkin for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Absci Corp Earnings Call Summary for Q1/2025
- Absci reported Q1 2025 revenue of $1.2M, with R&D expenses rising to $16.4M. Stock surged 8.1% in aftermarket trading to $3.20.
- Company transitioned to clinical-stage biotech, initiating first-in-human trial for ABS-101. Cash reserves increased to $134M, extending runway to 2027.
- Focus on AI-driven drug discovery and pharma partnerships. Plans to release ABS-101 interim data in H2 2025 and begin ABS-201 human studies in early 2026.
- CEO Sean McLean highlighted milestone of becoming clinical-stage biotech. CFO Zach Jonasen emphasized balanced approach for shareholder returns.
- Analysts revised earnings expectations downward, forecasting continued losses through 2025. Company faces challenges in R&D costs and competitive landscape.
Last Updated: 14-05-2025, 02:54 am
Read Full TranscriptCompare ABSI to Peers and Sector
Metrics to compare | ABSI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipABSIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.1x | −1.8x | −0.5x | |
PEG Ratio | −0.15 | −0.11 | 0.00 | |
Price/Book | 1.7x | 0.7x | 2.6x | |
Price / LTM Sales | 69.9x | 15.0x | 3.1x | |
Upside (Analyst Target) | 240.9% | 234.3% | 47.8% | |
Fair Value Upside | Unlock | 23.2% | 6.9% | Unlock |
Analyst Ratings
9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 9.125
(+245.64% Upside)
Earnings
Latest Release
May 13, 2025
EPS / Forecast
-0.21 / -0.22
Revenue / Forecast
1.18M / 2.61M
FAQ
What Is the Absci (ABSI) Stock Price Today?
The Absci stock price today is 2.64.
What Stock Exchange Does Absci Trade On?
Absci is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Absci?
The stock symbol for Absci is "ABSI."
What Is the Absci Market Cap?
As of today, Absci market cap is 336.76M.
What Is Absci's Earnings Per Share (TTM)?
The Absci EPS (TTM) is -0.92.
When Is the Next Absci Earnings Date?
Absci will release its next earnings report on 18 Aug 2025.
From a Technical Analysis Perspective, Is ABSI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Absci Stock Split?
Absci has split 0 times.
How Many Employees Does Absci Have?
Absci has 157 employees.
What is the current trading status of Absci (ABSI)?
As of 09 Jul 2025, Absci (ABSI) is trading at a price of 2.64, with a previous close of 2.64. The stock has fluctuated within a day range of 2.61 to 2.76, while its 52-week range spans from 2.01 to 6.33.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.